Niyazi M - Search Results

1

Impact of daily plan adaptation on accumulated doses in ultra-hypofractionated magnetic resonance-guided radiation therapy of prostate cancer.

Xiong Y, Rabe M, Rippke C, Kawula M, Nierer L, Klüter S, Belka C, Niyazi M, Hörner-Rieber J, Corradini S, Landry G, Kurz C. Xiong Y, et al. Among authors: niyazi m. Phys Imaging Radiat Oncol. 2024 Feb 25;29:100562. doi: 10.1016/j.phro.2024.100562. eCollection 2024 Jan. Phys Imaging Radiat Oncol. 2024. PMID: 38463219 Free PMC article.

2

Isobologram analysis of triple therapies.

Niyazi M, Belka C. Niyazi M, et al. Radiat Oncol. 2006 Oct 17;1:39. doi: 10.1186/1748-717X-1-39. Radiat Oncol. 2006. PMID: 17044920 Free PMC article.

3

Counting colonies of clonogenic assays by using densitometric software.

Niyazi M, Niyazi I, Belka C. Niyazi M, et al. Among authors: niyazi i. Radiat Oncol. 2007 Jan 9;2:4. doi: 10.1186/1748-717X-2-4. Radiat Oncol. 2007. PMID: 17212832 Free PMC article.

4

Efficacy of a triple treatment with irradiation, agonistic TRAIL receptor antibodies and EGFR blockade.

Niyazi M, Marini P, Daniel PT, Humphreys R, Jendrossek V, Belka C. Niyazi M, et al. Strahlenther Onkol. 2009 Jan;185(1):8-18. doi: 10.1007/s00066-009-1856-4. Epub 2009 Feb 18. Strahlenther Onkol. 2009. PMID: 19224142

5

Efficacy of triple therapies including ionising radiation, agonistic TRAIL antibodies and cisplatin.

Niyazi M, Marini P, Daniel PT, Humphreys R, Jendrossek V, Belka C. Niyazi M, et al. Oncol Rep. 2009 Jun;21(6):1455-60. doi: 10.3892/or_00000374. Oncol Rep. 2009. PMID: 19424623

6

Combination of the pro-apoptotic TRAIL-receptor antibody mapatumumab with ionizing radiation strongly increases long-term tumor control under ambient and hypoxic conditions.

Marini P, Budach W, Niyazi M, Junginger D, Stickl S, Jendrossek V, Belka C. Marini P, et al. Among authors: niyazi m. Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):198-202. doi: 10.1016/j.ijrobp.2009.04.038. Int J Radiat Oncol Biol Phys. 2009. PMID: 19695436

7

Combined treatment with lexatumumab and irradiation leads to strongly increased long term tumour control under normoxic and hypoxic conditions.

Marini P, Junginger D, Stickl S, Budach W, Niyazi M, Belka C. Marini P, et al. Among authors: niyazi m. Radiat Oncol. 2009 Oct 27;4:49. doi: 10.1186/1748-717X-4-49. Radiat Oncol. 2009. PMID: 19860913 Free PMC article.

8

Choline PET based dose-painting in prostate cancer--modelling of dose effects.

Niyazi M, Bartenstein P, Belka C, Ganswindt U. Niyazi M, et al. Radiat Oncol. 2010 Mar 18;5:23. doi: 10.1186/1748-717X-5-23. Radiat Oncol. 2010. PMID: 20298546 Free PMC article.

9

Long-term outcome of mitomycin C- and 5-FU-based primary radiochemotherapy for esophageal cancer.

Wolf M, Zehentmayr F, Niyazi M, Ganswindt U, Haimerl W, Schmidt M, Hölzel D, Belka C. Wolf M, et al. Among authors: niyazi m. Strahlenther Onkol. 2010 Jul;186(7):374-81. doi: 10.1007/s00066-010-2137-y. Epub 2010 Jun 24. Strahlenther Onkol. 2010. PMID: 20582393

10

Irradiation and bevacizumab in high-grade glioma retreatment settings.

Niyazi M, Ganswindt U, Schwarz SB, Kreth FW, Tonn JC, Geisler J, la Fougère C, Ertl L, Linn J, Siefert A, Belka C. Niyazi M, et al. Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):67-76. doi: 10.1016/j.ijrobp.2010.09.002. Epub 2010 Oct 27. Int J Radiat Oncol Biol Phys. 2012. PMID: 21030162

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

320 results

Search Page

Filters